NanoViricides Inc.

Gainers CytoMed Therapeutics Limited (NASDAQ: GDTC) shares surged 109.2% to $7.30 in pre-market trading after gaining 9% on Monday. Better Therapeutics, Inc. (NASDAQ: BTTX) shares gained 51.1% to $1.36 in pre-market trading after the FDA approved the company's AspyreRx prescription-only digital therapeutic treatment to provide cognitive behavioral therapy to adult patients with type 2 diabetes. Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares rose 42.2% to $0.1450 in pre-market trading after declining around 14% on Monday. Trinity Place Holdings Inc. (NYSE: TPHS) gained 24.1% to $0.6790 in pre-market trading after declining around 15% on Monday. TC Biopharm (Holdings) Plc (NASDAQ: TCBP) shares rose 20.8% to $0.54 in pre-market trading. NanoViricides, Inc. (NYSE: NNVC) rose 19.9% to $1.69 in pre-market trading. NanoViricides reported effectiveness of antiviral clinical drug candidate NV-387 in an animal model of lethal lung infection with respiratory syncytial virus. Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) shares climbed 18.2% to $5.86 in pre-market trading. Acumen Pharmaceuticals recently announced it ...

Related tickers: VRDN, EZFL, REE, BTTX, DSS, TCBP, NNVC, RVYL, TPHS, CACO, GDTC, TTOO, DERM, ABOS, IOVA, UGRO, CRKN, JUPW, TTCF, CNEY.

SHELTON, Conn., May 04, 2023 (GLOBE NEWSWIRE) -- (via IBN) -- NanoViricides, Inc. (NYSE American: NNVC) (the “Company”), a clinical stage global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, announces that Anil R. Diwan, Ph.D., President of the Company will be presenting at The Inaugural EF Hutton Global Conference, which will be held on May 10-11, 2023, at the Plaza Hotel in the heart of New York City. NanoViricides is presenting on May 10th.

Related tickers: NNVC.